Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 32

Trial Status

Completed4

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT01915771Phase 1Completed
Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects
Intra-subject Variability of Pharmacokinetics
StudychairStart date: 2013-07-29
NCT00943306Phase 3Completed
Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia
Familial Hypercholesterolemia
StudychairStart date: 2009-10-29

Research Network

Collaboration Network

6 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Marina Cuchel, MD, PhD

University of Pennsylvania

Moderately Similar
9 trials

Shared therapeutic areas:

HealthyHyperlipoproteinemia Type IIHomozygous Familial Hypercholesterolemia

Worked with same sponsors:

Aegerion Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score34%

Ulrike Lorch, MD

Richmond Pharmacology Limited

Related
2 trials

Shared therapeutic areas:

HealthyIntra-subject Variability of Pharmacokinetics

Worked with same sponsors:

Aegerion Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score24%

Ulrike Lorch, MD

Richmond Phamacology, LTD

Related
1 trials

Shared therapeutic areas:

Healthy

Worked with same sponsors:

Aegerion Pharmaceuticals, Inc.
Collaborated on 1 trial
Similarity Score14%

Marina Cuchel, MD, PhD

Univerity of Pennsylvania

Related
1 trials

Shared therapeutic areas:

Homozygous Familial Hypercholesterolemia

Worked with same sponsors:

Aegerion Pharmaceuticals, Inc.FDA Office of Orphan Products Development
Collaborated on 1 trial
Similarity Score14%

emilie garrido pradalie

APHM

Related
35 trials

Shared therapeutic areas:

Healthy
Similarity Score8%

Waqar ahmed awan, Phd

Riphah International University

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score8%

David Meeker, MD

Rhythm Pharmaceuticals, Inc.

Related
19 trials

Shared therapeutic areas:

Healthy
Similarity Score8%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Healthy
Similarity Score8%

Murad Alam, MD

Northwestern University

Related
65 trials

Shared therapeutic areas:

Healthy
Similarity Score8%

Ahmed Elshafeey, Ph.D. Pharma

Genuine Research Center

Related
34 trials

Shared therapeutic areas:

Healthy
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT02044419Phase 1StudyChair

A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled

Healthy
Completed
NCT01915771Phase 1StudyChair

Study to Determine the Intra-subject Variability of Pharmacokinetics of Lomitapide in Healthy Subjects

Intra-subject Variability of Pharmacokinetics
Completed
NCT00943306Phase 3StudyChair

Long Term, Follow-on Study of Lomitapide in Patients With Homozygous Familial Hypercholesterolemia

Familial Hypercholesterolemia
Completed
NCT00730236Phase 3StudyDirector

A Safety and Efficacy Study of AEGR-733 to Treat Homozygous Familial Hypercholesterolemia (FH)

Homozygous Familial Hypercholesterolemia
Completed

All 4 trials loaded